SDZ MRL 953, a novel immunostimulatory monosaccharidic lipid A analog with an improved therapeutic window in experimental sepsis.

SDZ MRL 953, a new synthetic monosaccharidic lipid A, was investigated in vitro and in vivo for immunopharmacological activities. In experimental models of microbial infections, the compound was highly protective when it was administered prophylactically either once or three times to myelosuppressed...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Lam, C, Schütze, E, Hildebrandt, J, Aschauer, H, Liehl, E, Macher, I, Stütz, P
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1991
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245039/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2039200/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.3.500
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!